Replies to post #28392 on DNAprint Genomics (DNAG)

[Miss Scarlet]

Froggy ~

What are you doing here? I thought you were at the meeting with your list of questions.

Warm Regards,

[Blue Juggernaut]

Frogdreaming, very nicely put. You have bridged the gap between patent approval and the ending plausible inference of, you could discern that the statin patent could pay nicely. I had assumed that most would understand how to get from A to B; however, you painted a clearer picture for everyone that cares to look.
Big Blue

[ole vern]

Froggie,

Good points. Being a pharmacist and having some
insight to the climate of prescribing, I have had
some doubts about the value of Statinome to the general public. Since such a small percentage of patients
are actually at risk, will the cost of the test be justifiable for routine use? Unless it is inexpensive, I just don't see all the practitioners scrambling to use it, or insurance companies considering it as a necessity. It would enjoy
its greatest value for those few patients who have taken
a statin before and have shown symptoms of muscle damage.
These patients could certainly use such a test to determine
which statin could be used safely. But otherwise....(biting tongue)